Quality of Life in Multiple Myeloma Patients Treated With Bortezomib

NCT01021592 · clinicaltrials.gov ↗

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: bortezomib

Sponsor

Janssen Korea, Ltd., Korea